Apella Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Apella Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$669K	Sell	4,080 -97	-2%	-$13.1K	0.01%	418
2026 Q1	$579K	Buy	4,177 +157	+4%	+$19.6K	0.01%	435
2025 Q4	$490K	Buy	+4,020	New	+$461K	0.01%	365
2021 Q3	–	Sell	-5,452	Closed	-$738K	–	214
2021 Q2	$738K	Buy	+5,452	New	+$717K	0.12%	111

Other funds holding XBI

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

RAM

Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Apella Capital's XBI Position: Q2 2026 in Review

Apella Capital reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.3% in Q2 2026, selling an estimated $13.1K and leaving 4,080 shares worth $669K. The position accounts for 0.01% of the portfolio, ranked #418.

Apella Capital first reported a position in XBI in Q2 2021 and has held it in 4 quarters since. The position peaked at $738K in Q2 2021. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Apella Capital held 4,080 shares of State Street SPDR S&P Biotech ETF worth $669K as of Q2 2026.
Apella Capital sold 97 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $13.1K.
State Street SPDR S&P Biotech ETF made up 0.01% of Apella Capital's portfolio in Q2 2026, its #418 holding.
Apella Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and has held it in 4 quarters since.
Apella Capital's State Street SPDR S&P Biotech ETF position peaked at $738K in Q2 2021.
393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.